Alan B. Lancz & Associates’s Honeywell HON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$860K Sell
3,840
-3,839
-50% -$857K 0.75% 26
2026
Q1
$1.74M Buy
7,679
+18
+0.2% +$4.11K 1.68% 11
2025
Q4
$1.49M Buy
7,661
+63
+0.8% +$12.3K 1.31% 15
2025
Q3
$1.51M Hold
7,598
1.36% 14
2025
Q2
$1.67M Hold
7,598
1.67% 12
2025
Q1
$1.52M Sell
7,598
-212
-3% -$42.9K 1.62% 12
2024
Q4
$1.66M Sell
7,810
-1,061
-12% -$221K 1.69% 12
2024
Q3
$1.73M Buy
8,871
+424
+5% +$82.2K 1.59% 12
2024
Q2
$1.7M Buy
+8,447
New +$1.61M 1.68% 13
2023
Q4
$1.73M Hold
8,765
1.82% 10
2023
Q3
$1.53M Hold
8,765
1.73% 10
2023
Q2
$1.71M Hold
8,765
1.83% 9
2023
Q1
$1.58M Hold
8,765
1.64% 11
2022
Q4
$1.79M Hold
8,765
1.81% 10
2022
Q3
$1.38M Hold
8,765
1.64% 10
2022
Q2
$1.59M Hold
8,765
1.57% 10
2022
Q1
$1.61M Hold
8,765
1.42% 15
2021
Q4
$1.72M Buy
+8,765
New +$1.77M 1.51% 14

Other funds holding HON

Alan B. Lancz & Associates's HON Position: Q2 2026 in Review

Alan B. Lancz & Associates reduced its Honeywell (HON) stake by 50% in Q2 2026, selling an estimated $857K and leaving 3,840 shares worth $860K. The position accounts for 0.75% of the portfolio, ranked #26.

Alan B. Lancz & Associates first reported a position in HON in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.79M in Q4 2022. 2,155 funds tracked by Wall St. Rank hold HON as of Q2 2026.

  • Alan B. Lancz & Associates held 3,840 shares of Honeywell worth $860K as of Q2 2026.
  • Alan B. Lancz & Associates sold 3,839 Honeywell shares in Q2 2026, an estimated $857K.
  • Honeywell made up 0.75% of Alan B. Lancz & Associates's portfolio in Q2 2026, its #26 holding.
  • Alan B. Lancz & Associates first reported a position in Honeywell in Q4 2021 and has held it in 18 quarters since.
  • Alan B. Lancz & Associates's Honeywell position peaked at $1.79M in Q4 2022.
  • 2,155 funds tracked by Wall St. Rank held Honeywell as of Q2 2026.

Based on Alan B. Lancz & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.